Fortuitous in vitro compound degradation produces a tractable hit against Mycobacterium tuberculosis dethiobiotin synthetase: a cautionary tale of what goes in, does not always come out
W. Salaemae, A. P. Thompson, B. I. Gaiser, K. J. Lee, M. T. Huxley, C. J. Sumby, S. W. Polyak, A. D. Abell, J. B. Bruning, K. L. Wegener
The paper describes how a fragment compound was inadvertently modified in crystal conditions, leading to a potent inhibitor of Mycobacterium tuberculosis dethiobiotin synthetase.
bioRxiv · Mar 26, 2023 · PreprintBiochemistry